TDE-expressed NKG2D ligands, including the major histocompatibility complex class I polypeptide-related sequence A and B (MICA/B) and a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10), are also considered as the “pseudoligands” to neutralize NKG2D in neuroblastoma [144]. This evidence concerns the gene KLRK1 and neuroblastoma.